WHO ICTRP trial
Estudio fase II randomizado de Capecitabina + Bevacizumab versus Capecitabina +…
EUCTR2009-010192-24-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2009-010192-24-ES |
|---|---|
| Public title | Estudio fase II randomizado de Capecitabina + Bevacizumab versus Capecitabina + Oxaliplatino + Bevacizumab en combinación con radioterapia externa como tratamiento preoperatorio en pacientes con cáncer rectal localmente avanzado resecable - AVAROX |
| Scientific title | Estudio fase II randomizado de Capecitabina + Bevacizumab versus Capecitabina + Oxaliplatino + Bevacizumab en combinación con radioterapia externa como tratamiento preoperatorio en pacientes con cáncer rectal localmente avanzado resecable - AVAROX |
| Primary sponsor | Grupo de Tratamiento de los Tumores Digestivos (TTD) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | cáncer rectal localmente avanzado resecable MedDRA version: 9 Level: LLT Classification code 10038038 Term: Rectal cancer |
| Interventions | Trade Name: AVASTIN 25 mg/ml concentrado para solución para perfusión Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: BEVACIZUMAB Other descriptive name: BEVACIZUMAB Concentration unit: mg/ml… |
| Registration date | Mar 31, 2009 |
| Secondary IDs | TTD-08-05 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: